Recombinant human anti–transforming growth factor β1 antibody therapy in systemic sclerosis: A multicenter, randomized, placebo-controlled phase I/II trial of CAT-192-Reference-Cited by-同舟云学术

Recombinant human anti–transforming growth factor β1 antibody therapy in systemic sclerosis: A multicenter, randomized, placebo-controlled phase I/II trial of CAT-192

Published:2006 Issue:1 Volume:56 Page:323-333
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis Rheum

Author:

Denton Christopher P.,Merkel Peter A.,Furst Daniel E.,Khanna Dinesh,Emery Paul,Hsu Vivien M.,Silliman Nancy,Streisand James,Powell John,Åkesson Anita,Coppock John,Hoogen Frank van den,Herrick Ariane,Mayes Maureen D.,Veale Douglas,Haas Joanna,Ledbetter Stephen,Korn Joseph H.,Black Carol M.,Seibold James R.,

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference38 articles.

1. Immunocytochemical Localization and Serologic Detection of Transforming Growth Factor β1

2. Expression of TGF-β1, -β2 and -β3 in localized and systemic scleroderma

3. Increased transcriptional activities of transforming growth factor ? receptors in scleroderma fibroblasts

4. Autocrine Overexpression of CTGF Maintains Fibrosis: RDA Analysis of Fibrosis Genes in Systemic Sclerosis

5. A modified model of graft-versus-host-induced systemic sclerosis (scleroderma) exhibits all major aspects of the human disease

Cited by 403 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The current landscape of antifibrotic therapy across different organs: A systematic approach;Pharmacological Research;2024-07

2. Type-2 immunity associated with type-1 related skin inflammatory diseases: friend or foe?;Frontiers in Immunology;2024-05-29

3. Differential expression of small bowel TGFβ1 and TGFβ3 characterizes intestinal strictures in patients with fibrostenotic Crohn’s disease;Histochemistry and Cell Biology;2024-05-05

4. A Phase 1a Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7303509, an Anti-TGFβ3 Antibody, in Healthy Volunteers;Rheumatology and Therapy;2024-04-25

5. A two-way street – cellular metabolism and myofibroblast contraction;npj Regenerative Medicine;2024-04-03